Journal of Obesity & Metabolic Syndrome



Korean J Obes 2013; 22(4): 231-236

Published online December 31, 2013

Copyright © Korean Society for the Study of Obesity.

The Effect of Obesity Management Program on Blood Lipid Profile and Adiponectin in Obese Women

Jung-Soon Han*, Choon Koo Zhoh(1), Eun Ju Lee(1)

Dokhaksa College in Lifelong Center of Seoul National University of Education; and Department of Chemical Engineering, Soongsil University(1)

Received: August 12, 2013; Reviewed : August 20, 2013; Accepted: October 15, 2013

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Background: The incidence of obesity and the risk of metabolic disorders and many other additional health problems have dramatically increased among middle aged obese women. Effective obesity management programs are crucial for promoting health in middle aged obese women. Therefore this study was undertaken with the objective of developing an effective program applicable to middle aged obese women.
Methods: The study subjects were middle aged obese women (n = 36) whose body mass index (BMI) was greater than 25 kg/m2. Thirty six participants were randomly divided into two groups. They were assigned to either the Nutrition and Exercise (NE) program or the Exercise (E) program. Both programs were conducted for 3 months. We measured each subject's body weight, body mass index, body fat, serum lipid profile, adiponectin, and high sensitivity C-reactive protein level.
Results: Body weight and BMI significantly decreased in NE group than in E group. The serum levels of total cholesterol decreased while adiponectin was increased in NE group in contrast to E group.
Conclusion: These results show that continuous NE program will promote health in middle aged obese women compared to only E program.

Keywords: Obesity, Women, Adiponectin, Blood lipid profile

The baseline clinical characteristics of participants

The comparison of anthropometry between NE and E group in middle aged obese women

The comparison of total cholesterol, free fatty acid, HDL-cholesterol and triglyceride between NE and E group in middle aged obese women

The comparison of adiponectin, and hs-CRP between NE and E group in middle aged obese women

  1. Korea Center for Disease Control and Prevention. Korea Health Statistics 2009 : Quality control and analysis support on nutrition survey of KNHANES Ⅳ. Seoul: Korea Center for Disease Control and Prevention; 2010.
  2. Hahn D, Payne W, Lucas E. Focus on health. 11th ed. New York: McGrow Hill Humanities; 2013. p. 125-53.
  3. Korea Institute for Health and Social Affairs. Korean Women's Health Statistics. Seoul: Korea Institute for Health and Social Affairs; 2004.
  4. Lee JK, Yu BY, Cho DY. Relations between obesity indices and smoking, alcohol, lipid, blood glucose and blood pressure. The Kon-Kuk Journal of Medical Sciences 2000;10:111-8.
  5. Lee SE, Moon JH, Ahn JH, Oh YS, Shinn SH. The Association between plasma adiponectin and the components of metabolic syndrome in adults with abdominal obesity. Korean J Obes 2007;16:147-53.
  6. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
    Pubmed CrossRef
  7. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6.
    Pubmed CrossRef
  8. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP -activated protein kinase. Nat Med 2002;8:1288-95.
    Pubmed CrossRef
  9. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-9.
    Pubmed CrossRef
  10. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-33.
    Pubmed CrossRef
  11. Yi KN, Kwon OH. Clinical pathology file. 3rd ed. Seoul: Medrang, Inforang; 2000. p. 14-62.
  12. Spranger J, Kroke A, M?hlig M, Bergmann MM, Ristow M, Boeing H, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226 -8.
  13. Otsuji S, Shibata H, Umeda M. Turbidimetric immunoassay of serum C-reactive protein. Clin Chem 1982;28:2121-4.
  14. Lemieux I, Pascot A, Prud'homme D, Alm?ras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol 2001;21:961-7.
    Pubmed CrossRef
  15. Christensen JR, Faber A, Ekner D, Overgaard K, Holtermann A, Søgaard K. Diet, physical exercise and cognitive behavioral training as a combined workplace based intervention to reduce body weight and increase physical capacity in health care workers-a randomized controlled trial. BMC Public Health 2011;11:671.
    Pubmed KoreaMed CrossRef
  16. Kim MS, Ahn HS. Dietary intakes and serum component in middle aged abdominal obese women. Korean J Obes 2003;12:124-36.
  17. Reyes M, Gahagan S, D?az E, Blanco E, Leiva L, Lera L, et al. Relationship of adiposity and insulin resistance mediated by inflammation in a group of overweight and obese Chilean adolescents. Nutr J 2011;10:4.
    Pubmed KoreaMed CrossRef